These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3939 related articles for article (PubMed ID: 5372756)

  • 21. [Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations].
    Kulik GI
    Biull Eksp Biol Med; 1969 Dec; 68(12):68-70. PubMed ID: 4986230
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cytostatic action of N-ethyl-13-dihydrorubomycin on the cells of various tumor strains].
    Volkolupova OP
    Antibiotiki; 1984 Jun; 29(6):435-7. PubMed ID: 6548103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Toxicity and antineoplastic activity of some ethers of phosphoric and phosphinic acid].
    Minakova SM; Chernov VA
    Farmakol Toksikol; 1967; 30(4):479-80. PubMed ID: 5598906
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of the chemical structure on the biological endency of cytostatic compounds related to dibromomannitol. I. Structure-activity correlations.
    Institóris L; Horváth IP; Csányi E
    Arzneimittelforschung; 1967 Feb; 17(2):145-9. PubMed ID: 5631481
    [No Abstract]   [Full Text] [Related]  

  • 25. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Action of khanerol on the superhelical DNA structure of S-37 cells].
    Struchkov VA; Suslova OA; Lobachev VM
    Eksp Onkol; 1988; 10(4):52-4. PubMed ID: 3181075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-tumor and estrogenic activity of derivatives of various hormones with ethylene imido-phosphoric acid residues].
    Chernov VA; Minakova SM; Grushina AA
    Vopr Onkol; 1968; 14(11):69-75. PubMed ID: 5753347
    [No Abstract]   [Full Text] [Related]  

  • 28. [Distribution of asaphan-C14 in the organs of both sexes].
    Lobova TG; Sof'ina ZP
    Vopr Onkol; 1968; 14(10):79-82. PubMed ID: 5724802
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of the sensitivity of clones from transplantable mouse tumor (sarcoma 37) to antineoplastic agents].
    Sharlikova LF
    Tsitologiia; 1965; 7(3):408-10. PubMed ID: 5879869
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of 11-deoxycorticosterone acetate on the anti-tumor activity of spirazidin in rats with sarcoma 45].
    Grushina AA; Sorkina IuA; Chernov VA
    Vopr Onkol; 1971; 17(9):91-4. PubMed ID: 5138814
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antineoplastic effect and toxicity of the alkaloid of Crotalaria assamica].
    Zhonghua Yi Xue Za Zhi; 1973; 8():472-7. PubMed ID: 4200745
    [No Abstract]   [Full Text] [Related]  

  • 32. The influence of combined glycolytic inhibitor, respiratory inhibitor, and protein antagonist on experimental tumor growth.
    Silverstein MN; Linman JW
    Mayo Clin Proc; 1967 Jun; 42(6):313-7. PubMed ID: 6025632
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma.
    Fraker DL; Alexander HR
    Important Adv Oncol; 1994; ():179-92. PubMed ID: 8206489
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antineoplastic activity of preparations of the series of phenoxazine dyes].
    D'iachkovskaia RF; Parkhomenko II; Vasil'eva LS; Surkova NI; Shuppe NG; Konovalova NP; Bogdanov GN; Emanuel' NM
    Farmakol Toksikol; 1969; 32(1):84-7. PubMed ID: 5770324
    [No Abstract]   [Full Text] [Related]  

  • 35. [Transplantability of sarcoma 298 following a single administration of sarcolysine].
    Merkulov MF; Talipov ASh
    Farmakol Toksikol; 1971; 34(6):725-8. PubMed ID: 5139798
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the cytostatic action "in vivo" of some new synthetic carbamic esters. Action of a new O-tertiary-alkylated urethane in the treatment of experimental cancer].
    Teitel A; Chiritza C; Demetresco C; Gork E; Mavrodin A
    Therapie; 1965; 20(6):1431-42. PubMed ID: 5855991
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of nucleic acids for estimation of tumor cell growth in diffusion chambers].
    Smetankina OZ; Platonova GN; Sof'ina ZP
    Vopr Onkol; 1977; 23(4):57-61. PubMed ID: 883196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of tumor necrosis factor in isolated hepatic perfusion.
    Fraker DL; Alexander HR; Thom AK
    Circ Shock; 1994 Sep; 44(1):45-50. PubMed ID: 7704938
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of the agar diffusion chamber for the exposure of human tumor cells to drugs.
    Selby PJ; Steel GG
    Cancer Res; 1982 Nov; 42(11):4758-62. PubMed ID: 7127312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transplantation of isologous bone marrow to mice after administration of LD-90 sarcolysin].
    Iurchenko NIa
    Vopr Onkol; 1966; 12(11):62-7. PubMed ID: 6003516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 197.